Literature DB >> 30908089

Two new alkaloids from the tubers of Corydalis ambigua subsp. amurensis and their anti-proliferative activity.

Zhihui Liu1,2, Zhenru Mi1,2, Panpan Wang1,2, Sheng Chang1,2, Na Han1,2, Jun Yin1,2.   

Abstract

Two new alkaloids, including one benzophenanthridine type, dehydroambiguanine A (1) and one isoquinoline type, ambiguanine J (2) together with four (3-6) known alkaloids were isolated from the n-butanol fraction of Corydalis ambigua subsp. amurensis. Their structures were elucidated by comprehensive spectroscopic methods including HR-ESIMS and NMR, and the absolute configuration of compound 1 was further confirmed by the quantum ECD calculations. In addition, all isolated alkaloids (1-6) were determined their anti-proliferative effects of on A549 and HCT 116 cell by colorimetric MTT assay. Among them, Compounds 1 and 4 exhibited anti-proliferative activity on HCT 116 cell line with the IC50 value at 49.8 ± 4.79, and 89.2 ± 1.86 μM, respectively. Compounds 2 and 5 showed mild anti-proliferative activity against A549 cell with IC50 values at 60.2 ± 10.7, and 89.2 ± 12.9 μM, respectively. Their preliminary structure-activity relationship was also discussed.

Entities:  

Keywords:  Alkaloids; anti-proliferative activity; corydalis ambigua subsp. amurensis

Mesh:

Substances:

Year:  2019        PMID: 30908089     DOI: 10.1080/14786419.2019.1566821

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  2 in total

1.  Majie Cataplasm Promotes Th1 Response to Fight against Asthmatic Th2 Inflammation through NKs.

Authors:  Wenting Ji; Hanfen Shi; Tianyi Feng; Shuang Zhang; Haixia Liu; Wenxiu Xu; Xueqian Wang; Qingguo Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-12       Impact factor: 2.650

2.  The mediatory role of Majie cataplasm on inflammation of allergic asthma through transcription factors related to Th1 and Th2.

Authors:  Wenting Ji; Qianyi Zhang; Hanfen Shi; Ruijuan Dong; Dongyu Ge; Xin Du; Beida Ren; Xueqian Wang; Qingguo Wang
Journal:  Chin Med       Date:  2020-05-24       Impact factor: 5.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.